483 GlaxoSmithKline Biologicals SA Jan 2017

483 GlaxoSmithKline Biologicals SA Jan 2017

Gene Arcy FDA, Susan Jackson FDA, Cynthia Jim FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline Biologicals SA - Rixensart, Belgium facility and issued inspectional observations (via FDA 483) on 27 Jan 2017.

Product details

  • Category: Biologics
  • Inspection end: 27 Jan 2017
  • Location: Rixensart, Belgium
  • FEI: 3002875226
Add To Cart